Johnson & Johnson to Acquire Auris Health for its Monarch Technology for $5.7B

 Johnson & Johnson to Acquire Auris Health for its Monarch Technology for $5.7B

Johnson & Johnson to Acquire Auris Health for its Monarch Technology for $5.7B

Shots:

  • J&J acquires Auris Health, in allstock transaction for $5.7B as total deal value, including $3.4B upfront in cash and $2.35B milestones. The transaction is expected to close in Q2’19
  • The focus of the agreement is to advance surgical treatments in connection with digital technologies for the treatment of lung cancer including open, laparoscopic, robotic and endoluminal surgeries
  • Auris Health’s Monarch Platform is an endoscopic robotic technology with advancement in micro-instrumentation, sensing, & data science in one platform for improved outcomes

Click here to read full press release/ article | Ref: J&J | Image: Twitter

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post